CytomX Therapeutics Inc (CTMX)
4.70
+0.21
(+4.70%)
USD |
NASDAQ |
May 03, 10:25
CytomX Therapeutics Cash and Short Term Investments (Quarterly): 174.51M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 174.51M |
September 30, 2023 | 194.11M |
June 30, 2023 | 180.86M |
March 31, 2023 | 204.50M |
December 31, 2022 | 193.65M |
September 30, 2022 | 194.29M |
June 30, 2022 | 228.16M |
March 31, 2022 | 262.53M |
December 31, 2021 | 305.23M |
September 30, 2021 | 236.29M |
June 30, 2021 | 266.18M |
March 31, 2021 | 393.80M |
December 31, 2020 | 316.12M |
September 30, 2020 | 321.08M |
June 30, 2020 | 346.40M |
March 31, 2020 | 247.92M |
December 31, 2019 | 296.14M |
September 30, 2019 | 325.71M |
Date | Value |
---|---|
June 30, 2019 | 349.14M |
March 31, 2019 | 396.60M |
December 31, 2018 | 436.13M |
September 30, 2018 | 464.56M |
June 30, 2018 | 335.15M |
March 31, 2018 | 361.48M |
December 31, 2017 | 374.11M |
September 30, 2017 | 331.28M |
June 30, 2017 | 335.92M |
March 31, 2017 | 162.52M |
December 31, 2016 | 181.94M |
September 30, 2016 | 178.46M |
June 30, 2016 | 195.80M |
March 31, 2016 | 180.64M |
December 31, 2015 | 186.71M |
September 30, 2015 | 113.69M |
June 30, 2015 | 125.37M |
December 31, 2014 | 64.40M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
174.51M
Minimum
Dec 2023
393.80M
Maximum
Mar 2021
265.09M
Average
262.53M
Median
Mar 2022
Cash and Short Term Investments (Quarterly) Benchmarks
Ocular Therapeutix Inc | 195.81M |
Bristol-Myers Squibb Co | 9.67B |
ACADIA Pharmaceuticals Inc | 438.86M |
Cytokinetics Inc | 614.82M |
Calidi Biotherapeutics Inc | 1.949M |